ImmuCell Participating at Multiple Dairy and Beef Industry Events Throughout September 2014
Including World Dairy Expo -- The Largest Dairy Tradeshow in the World
(firmenpresse) - PORTLAND, ME -- (Marketwired) -- 09/17/14 -- (NASDAQ: ICCC) a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, announced today that it will be participating in a number of large industry tradeshows throughout the month of September.
The Company will be participating in the:
September 13 - 18, in Harrisburg, Pennsylvania;
September 18-20, in Albuquerque, New Mexico;
September 26 - 28, in Milwaukee, Wisconsin; and
September 30 - October 4, in Madison, Wisconsin.
Bobbi Jo Brockmann, director of sales and marketing, said, "This is an exciting time of the year for ImmuCell. These events afford opportunity, in addition to regular farm visits, to interface directly with our customers and distributors to bring them up to date on the value proposition that ImmuCell products provide to dairy and beef operators and their herds. With milk futures prices currently at all-time highs and strong beef prices, the benefits of to help newborn calves maximize their ability to become healthy and highly productive milk and beef producers becomes even more compelling."
"These are vital interactions in that they drive orders through our distribution channel as we approach the spring beef calving season which takes place in the March through May time frame. These events also provide our expanded sales and marketing team the opportunity to unite as a group and show our customers and distribution chain how we now have representation from all of the major cattle pockets in the U.S."
Ms. Brockmann continued, "Presence at these industry events also creates important corporate brand awareness as we continue to progress toward Food and Drug Administration (FDA) approval of to address subclinical mastitis in lactating cows. Subclinical and clinical mastitis costs the U.S. dairy industry upwards of $2 billion annually in treatment costs and lost milk revenue, among other issues. may provide a unique and effective solution to treat infections in their herd without the use of traditional antibiotics and without having to discard milk, driving a significant economic advantage. With , we expect to offer a powerful value proposition, and we look forward to bringing this important solution to the market."
ImmuCell has commenced validation and testing of processing equipment necessary to complete the manufacturing requirements of the New Animal Drug Application (NADA) submission to the FDA. The Company expects to make its first submission of the Chemistry, Manufacturing and Controls (CMC) Technical Section to the FDA during the first half of 2015. At the same time, Company scientists are working with the FDA to transfer the analytical method to detect Nisin in milk to an FDA laboratory. Once this method is successfully transferred, the Company expects to receive the Human Food Safety Technical Section Complete Letter from the FDA. These are the final two steps in the NADA process, as has previously received the following from the FDA:
Environmental Impact Technical Section Complete Letter;
Target Animal Safety Technical Section Complete Letter;
Effectiveness Technical Section Complete Letter; and
A zero milk discard and zero meat withhold claim.
The Company anticipates two, six-month reviews of the CMC Technical Section submission by the FDA, setting up potential NADA approval from the FDA during 2016. This would allow test marketing of in 2016.
ImmuCell Corporation''s (NASDAQ: ICCC) purpose is to create scientifically-proven and practical products that improve animal health and productivity in the dairy and beef industries. ImmuCell has developed products that provide significant immediate immunity to newborn dairy and beef livestock. The Company has also developed products that address mastitis, the most significant cause of economic loss to the dairy industry. Press releases and other information about the Company are available at our web-site, ().
Michael F. Brigham
President and CEO
(207) 878-2770
Joe Diaz, Robert Blum and Joe Dorame
Lytham Partners, LLC
(602) 889-9700
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.09.2014 - 06:00 Uhr
Sprache: Deutsch
News-ID 1302992
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PORTLAND, ME
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 63 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ImmuCell Participating at Multiple Dairy and Beef Industry Events Throughout September 2014
"
steht unter der journalistisch-redaktionellen Verantwortung von
ImmuCell Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
